22 results
PRE 14A
STOK
Stoke Therapeutics Inc
17 Apr 23
Preliminary proxy
4:01pm
during the fiscal year ended December 31, 2022 raised any conflict of interest.
Nominating and Corporate Governance Committee
Our Nominating … to review such transaction due to a conflict of interest. The policy provides that any request for us to enter into a transaction with an executive
S-3
EX-3.2
iyo84d59wy8
10 Jul 20
Shelf registration
4:06pm
S-3
EX-4.4
ho1ltneocjt2 q86yv6
10 Jul 20
Shelf registration
4:06pm
424B4
8n5i5icq
19 Jun 19
Prospectus supplement with pricing info
4:16pm
S-1/A
2xk398pb1nl6q
7 Jun 19
IPO registration (amended)
6:08am
S-1/A
EX-10.1
xbrc42izdkw2 m39c4
7 Jun 19
IPO registration (amended)
6:08am
S-1
EX-3.4
s1xjr9
23 May 19
IPO registration
4:02pm
S-1
EX-4.2
txb800ngzsvjjdxuy49
23 May 19
IPO registration
4:02pm
S-1
EX-10.10
8h5vfk0f5ug9cvjp
23 May 19
IPO registration
4:02pm
S-1
1t3sw0p
23 May 19
IPO registration
4:02pm
DRS/A
b70kq
30 Apr 19
Draft registration statement (amended)
12:00am